Immunotherapy and Radiotherapy for Older Cancer Pacients during the COVID-19 Era: Proposed Paradigm by te International Geriatric Radiotherapy Group

Gerontology

Fecha de publicación: Agosto de 2021

Autores: Nguyen N.P. · Baumert B.G. · Oboite E. · Motta M. · Appalanaido G.K. · Arenas M.^e · Lara P.C. · Bonet M. · Zamagni A. · Vuong T. · Popescu T. · Karlsson U. · Trigo L. · Sun Myint A. · Thariat J. · Vinh-Hung V.

DOI: https://doi.org/10.1159/000514451

Background: Older cancer patients with locally advanced or metastatic disease may benefit from chemotherapy alone or combined with radiotherapy. However, chemotherapy is often omitted either because of physician bias or because of its underlying comorbidity, thus compromising their survival.